entertainment -WSS

entertainment

author：hotspot 2025-09-29 00:34:08 - browse：3272

Silhouette of a person with short hair taking a sip of red wine in a winery — coverage from STAT — MARCO BERTORELLO/AFP via Getty Images

In 1995, when Marion Nestle was on the committee drafting the Dietary Guidelines for Americans, things were run differently. She and other experts handled it all: deciding on nutrition-related research questions, collecting the evidence, issuing a scientific report, and then writing guidance for how Americans should eat.

When it came time for that last part — the writing — Nestle and two co-authors got together at a bar, ordered glasses of wine, and got to work. “I’m not kidding,” she said. At the time, the research suggested small amounts of alcohol reduced the risk of heart disease. The guidelines reflected that. “Alcoholic beverages have been used to enhance the enjoyment of meals by many societies throughout human history,” read a part of the 1995 document (a note Nestle says was added last-minute by a federal official who believed in wine’s benefits).

The issue of alcohol — and how much of it Americans should consume — is up for debate again as the dietary guidelines undergo updates and revisions, due in 2025. Already, there’s simmering debate over a growing body of research, plus clashing of interests and the same specter of controversy that’s followed the report since Nestle’s time.

STAT+ Exclusive Story

Already have an account? Log in

This article is exclusive to STAT+ subscribers

Unlock this article — plus in-depth analysis, newsletters, premium events, and networking platform access.

Already have an account? Log in

Monthly

$39

Totals $468 per year

$39/month Get Started

Totals $468 per year

Starter

$30

for 3 months, then $39/month

$30 for 3 months Get Started

Then $39/month

Annual

$399

Save 15%

$399/year Get Started

Save 15%

11+ Users

Custom

Savings start at 25%!

Request A Quote Request A Quote

Savings start at 25%!

2-10 Users

$300

Annually per user

$300/year Get Started

$300 Annually per user

View All Plans

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Psychedelics group wrestles with new pharma identity
Next article： ALS treatment from Biogen, Ionis fails in study

WSS

FDA cancer chief on how to get things done: ‘Don’t tell anybody'

Publishing genetic code of viruses could cause disaster

Fertility clinic egg and embryo storage is a disaster

Obesity drug from Roche shows promise in early study

Readout Newsletter: Novo Nordisk trial, Verve base editing, etc

WuXi Biologics execs register to lobby as Congress comes for the company

explore

entertainment

This article is exclusive to STAT+ subscribers

Unlock this article — plus in-depth analysis, newsletters, premium events, and networking platform access.

knowledge

BioMarin wins approval for gene therapy to treat hemophilia A

The United States must get value

Continuity nursing helped my family in our darkest PICU moments

Oak Street deal isn't the answer to health care's woes

23andMe had bad news about my health. I wish a person had delivered it

Eli Lilly’s chief scientist on obesity drugs, gene editing, and more

Heart attack and stroke risk calculators need revising

Obesity drug from Roche shows promise in early study

What does generative AI mean for health care? We asked experts

Galapagos to make CAR

explore

Supreme Court to hear if Covid misinformation is protected speech

Galapagos to make CAR

Cancer diagnosis changes perspective doctor, former hospital CEO

How state and local governments are sidelining science

Abbott's new stent may help patients with peripheral artery disease

STAT series 'Denied by AI' wins major journalism prizes

entertainment

hotspot

hotspot

focus